Katherine Stueland, CHIEF EXECUTIVE OFFICER at GeneDx Holdings Corp. (WGS), sold 4,312 shares at $136.54 ($589K) on 2025-10-29, disclosed to the SEC on 2025-10-31.
Open-market sale of $589k WGS by CHIEF EXECUTIVE OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $136.54 | 2,154 | $294K | 50.0% |
| 2 | $136.54 | 2,154 | $294K | 50.0% |
| 3 | $136.75 | 4 | $547 | 0.1% |
| Total | $136.54 avg | 4,312 | $589K | 100% |
| Filing → |
| WGS | SELL | 2026-06-18 | $638K | — | Filing → |
| WGS | SELL | 2026-06-11 | $196K | — | Filing → |
| WGS | SELL | 2026-05-01 | $142K | — | Filing → |